Compositions and methods for treatment of infectious disease
    6.
    发明授权
    Compositions and methods for treatment of infectious disease 有权
    治疗传染病的组合物和方法

    公开(公告)号:US08202910B2

    公开(公告)日:2012-06-19

    申请号:US12255976

    申请日:2008-10-22

    摘要: Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis. In certain embodiments, the present invention comprises compositions comprising novel substituted ethylene diamine compounds further comprising antitubercular agents such as rifampicin, isoniazid, pyrazinamide and ethambutol.

    摘要翻译: 用于治疗由感染因子,特别是结核病引起的疾病的方法和组合物。 特别地,提供了包含用于治疗感染性疾病的取代的乙二胺的方法和组合物。 在一个实施方案中,这些方法和组合物用于治疗分枝杆菌感染,包括但不限于结核病。 在某些实施方案中,本发明包含还包含抗结核剂如利福平,异烟肼,吡嗪酰胺和乙胺丁醇的新型取代的乙二胺化合物的组合物。

    Protection from septic shock subsequent to injury by dsRNAs
    8.
    发明授权
    Protection from septic shock subsequent to injury by dsRNAs 失效
    保护免受dsRNA损伤后的脓毒性休克

    公开(公告)号:US5763417A

    公开(公告)日:1998-06-09

    申请号:US469625

    申请日:1995-06-06

    申请人: Leo Einck

    发明人: Leo Einck

    IPC分类号: A61K31/70 C12N20060101

    摘要: The use of dsRNA for use in the reactivation of natural defense systems within human cells, tissues and organs reduced to inadequate function subsequent to injury. Specific treatments for various clinical phases of the biological continuous of an acquired immune deficient state are described. Protection from the toxic effects associated with increased TNF levels is described.

    摘要翻译: 用于重新激活人类细胞,组织和器官中的天然防御系统的dsRNA在损伤后减少到功能不足。 描述了获得性免疫缺陷状态的生物连续的各种临床阶段的特异性治疗。 描述了与增加的TNF水平相关的毒性作用的保护。

    Methods and compositions for determining the pathogenic status of infectious agents
    9.
    发明授权
    Methods and compositions for determining the pathogenic status of infectious agents 有权
    用于确定感染因子的致病状态的方法和组合物

    公开(公告)号:US07919234B2

    公开(公告)日:2011-04-05

    申请号:US12080929

    申请日:2008-04-07

    IPC分类号: C12Q1/02 C12Q1/68 C12Q1/70

    CPC分类号: C12Q1/689

    摘要: Methods and compositions for the detection of disease caused by infectious agents and microbes are provided. In particular, methods and compositions comprising novel combinations of nucleic acid amplification and drug susceptibility technologies are provided. In certain embodiments, the present invention enables the detection of infectious agents and microbes as well as providing information concerning the viability status of the agent or microbe. In one embodiment, the present invention is used for the detection of mycobacterial infections, including, but not limited to, tuberculosis.

    摘要翻译: 提供了用于检测感染性和微生物引起的疾病的方法和组合物。 特别地,提供了包含核酸扩增和药物敏感性技术的新组合的方法和组合物。 在某些实施方案中,本发明能够检测感染因子和微生物以及提供关于试剂或微生物的活力状态的信息。 在一个实施方案中,本发明用于检​​测分枝杆菌感染,包括但不限于结核病。

    Methods and compositions for determining the pathogenic status of infectious agents
    10.
    发明申请
    Methods and compositions for determining the pathogenic status of infectious agents 有权
    用于确定感染因子的致病状态的方法和组合物

    公开(公告)号:US20110212457A1

    公开(公告)日:2011-09-01

    申请号:US13011754

    申请日:2011-01-21

    IPC分类号: C12Q1/68 C12N15/63

    CPC分类号: C12Q1/689 C12Q1/06 C12Q1/18

    摘要: The present invention relates to methods and compositions for improved detection of infectious agents and microbes. In particular, the present invention provides novel methods for detecting infectious agents, providing information about the viability status of such infectious agents and for determining drug susceptibility. In certain embodiments, the present invention employs techniques involving nucleic acid amplification-based microbial identification together with phage-based biological detection of drug resistance. The methods of the invention are suitable for all microbes and infectious agents, including bacterial agents such as Mycobacteria.

    摘要翻译: 本发明涉及用于改善感染因子和微生物检测的方法和组合物。 特别地,本发明提供了用于检测感染因子的新方法,提供关于这种感染剂的生存状态的信息和用于确定药物敏感性。 在某些实施方案中,本发明使用涉及基于核酸扩增的微生物鉴定以及基于噬菌体的药物抗性生物检测的技术。 本发明的方法适用于所有微生物和感染因子,包括细菌剂如分枝杆菌。